Background Myopia is a common refractive error, where elongation of the eyeball causes
distant objects to appear blurred. The increasing prevalence of myopia is a growing global …

Importance Early onset of myopia is associated with high myopia later in life, and myopia is
irreversible once developed. Objective To evaluate the efficacy of low-concentration …

Purpose (1) To compare the efficacy of continued and stopping treatment for 0.05%, 0.025%,
and 0.01% atropine during the third year.(2) To evaluate the efficacy of continued treatment …

Myopia is a dynamic and rapidly moving field, with ongoing research providing a better
understanding of the etiology leading to novel myopia control strategies. In 2019, the …

The prevalence of myopia is increasing across the world. Controlling myopia progression
would be beneficial to reduce adverse outcomes such as retinal detachment and myopic …

Purpose To evaluate the efficacy of a myopia control spectacle lens (DIMS) at slowing the
progression of myopia in a population of European children in comparison with 0.01 …

PURPOSE To evaluate longitudinal changes in subfoveal choroidal thickness (SFChT)
among children receiving atropine 0.05%, 0.025%, or 0.01% over 2 years and their …

TO THE EDITOR: Saxena et al 1 conducted a multicenter, doublemasked, placebo-
controlled randomized clinical trial in India and reported 1-year data proving efficacy of …

Purpose Defocus incorporated multiple segments (DIMS) spectacle lenses were reported to
slow myopia progression significantly in a randomized controlled trial (RCT). The study …

Background To investigate whether combining 0.01% atropine with orthokeratology (AOK)
has a better effect in retarding axial elongation, compared with orthokeratology alone (OK) …